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The use of mobile technologies to prevent sexually transmitted infections (STIs) is recognized 
as a promising approach worldwide, however evidence has been inconclusive and the field has 
developed rapidly. With about 1 million new STIs a day globally, up-to-date evidence is 
urgently needed. 
Objective 
To assess the effectiveness of mobile health interventions delivered to participants for 
preventing STIs and promoting preventive behaviour. 
Methods 
We searched seven databases and reference lists of 49 related reviews (January 1990-February 
2020) and contacted experts in the field. We included randomised controlled trials of mobile 
interventions delivered to adolescents and adults to prevent sexual transmission of STIs. We 
conducted meta-analyses and assessed risk of bias and certainty of evidence following 
Cochrane guidance. 
Results 
After double screening 6682 records, we included 22 trials into the systematic review and 20 
into meta-analyses; 18 trials used text messages, three used smartphone applications and one 
used Facebook messages as delivery modes. The certainty of evidence regarding intervention 
effects on STI/HIV occurrence and adverse events was low or very low. There was moderate 
certainty of evidence that in the short/medium-term text messaging interventions had little or 
no effect on condom use (SMD 0.02, 95% CI -0.09 to 0.14, 9 trials), but increased STI/HIV-
testing (OR 1.83, 95% CI 1.41 to 2.36, 7 trials); although not if the standard-of-care control 
already contained an active text messaging component (OR 1.00, 95% CI 0.68 to 1.47, 2 trials). 
Smartphone application messages also increased STI/HIV-testing (RR 1.40, 95% CI 1.22 to 
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1.60, subgroup analysis, 2 trials). The effects on other outcomes or of social media or blended 
interventions is uncertain due to low or very low certainty evidence. 
Conclusions 
Text messaging interventions probably increase STI/HIV-testing, but not condom use in the 





Among the biggest challenges within the field of sexual health are continuing high rates of 
sexually transmitted infections (STIs). Recent estimates of incident cases of the most frequent 
curable STIs (chlamydia, gonorrhoea, trichomoniasis and syphilis) amounted to a global total 
of 376 million infections in 2016, which translates to an average of approximately 1 million 
new infections each day1. Globally, sexual transmission is also the main transmission route of 
the human immunodeficiency virus (HIV). Although HIV incidence has recently declined 
compared to previous years, there were still 1.7 million new infections recorded globally in 
20192. 
 
Given the high burden of STIs in both high-income countries (HIC) and low- and middle- 
income countries (LMIC), researchers and governments in both settings have increasingly 
turned to mobile wireless technologies in search of new and cost-effective approaches for STI 
prevention3 4. Mobile technologies used in public health and health service settings 
(‘mHealth’)5 are appreciated for their “ease of use, broad reach and wide acceptance”6.  
Almost the entire world population (97%) lives within reach of a mobile cellular signal, and 
even in least developed countries (LDC) mobile cellular subscriptions have increased 
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drastically (2005-2019, from 5 to 75 per 100 inhabitants). There has also been an increase of 
active mobile broadband subscriptions per 100 inhabitants (2010-2019, from 12 to 83 
worldwide, and 0 to 33 in LDC)7. 
 
The rapid adoption of mobile technology globally offers unique and varied opportunities within 
the field of global health in general, and sexual health in particular. In general, supplying 
technology for mobile communication is often less expensive than providing in-person 
services4 5. Sexual health service users, in particular, also often prefer the anonymity and 
privacy of mobile solutions. As mobile phones are often carried by individuals wherever they 
go, they can act as reminders and allow for quick and easy access to stored information that 
can be listened to or read at an individual’s own time and pace and can be shared with others 
to facilitate communication about sensitive topics, such as sexual health8.  
 
Mobile phone delivered interventions employ a variety of different modes of delivery to 
improve different aspects of sexual health. This review focuses on mobile interventions with a 
‘push’ component, with information ‘delivered to participants’ (e.g. via video, voice or text 
messages) rather than being retrieved by them, as this has been described as a convenient, low-
commitment way to receive and share information and gain support relating to sexual health8 
9. After a number of pilot mHealth initiatives in various contexts, however, the WHO and others 
have called for increased rigour in the evaluation of mHealth interventions and also in the 
assessment of potential adverse effects4 10.  
 
Previous systematic reviews evaluating the effect of mHealth interventions on STI prevention 
have reported promising, but inconclusive results3 11 12. The most recently published meta-
analyses reported that interventions may increase knowledge, STI testing and service use and 
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may not increase condom use, but the evidence was low certainty and the effects of 
interventions on partner notification, curable STI treatment adherence and STI/ HIV incidence 
is not known13 14. The mHealth literature has grown rapidly and further studies have been 
published since the most recent searches for these reviews were completed in 2017. To our 
knowledge, no up-to-date meta-analyses have been published that respond directly to our 
research question10 15-17: Are sexual health interventions delivered to participants by mobile 
technology effective in preventing STIs or promoting preventive behaviour among adolescents 
and adults if compared with an inactive control intervention? 
 
METHODS 
We conducted a systematic review and meta-analysis following Cochrane and PRISMA 
guidelines18 19 (Suppl.1) after registering our protocol20.  
 
Eligibility criteria  
We included randomised controlled trials (RCT) conducted worldwide among (potential) 
sexual health service users aged ≥10 years to evaluate mHealth interventions with a ‘push’ 
component focused on the sexual transmission of STIs, including HIV. (We define a ‘push’ 
component as intervention content that users receive without active request or engagement, 
beyond having signed up to receive the intervention initially.) To limit the scope of this review, 
we excluded studies that focused on voice calls alone (e.g. phone counselling sessions instead 
of face-to-face sessions that could also have been done via landlines), as well as emails, or 
websites alone, and did not necessarily require mobile devices and/or did not contain a ‘push’ 
component. We also excluded studies with interventions that are relevant for HIV prevention 
only, and only included trials with an ‘inactive’ control intervention, i.e. no intervention, 
standard-of-care (SOC), placebo, or waiting list control. We pre-specified the following most 
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important outcomes for our review (to be included in the summary of findings table): 
Biological outcomes, including long term (at ≥12 months) STI/HIV occurrence (objectively 
confirmed), short/medium term (<12 months) STI/HIV occurrence (objectively confirmed and 
subjective/self-reported); adverse effects, including experience of violence; behavioural 
outcomes, including condom use, compliance with treatment instructions for curable STIs, STI 
(self-)testing, and partner notification. Other review outcomes included costs and cognitive 
outcomes, such as STI-related knowledge or self-efficacy (Suppl.2).  
 
Search strategy 
We searched seven electronic bibliographic databases/trial registers (MEDLINE, Embase, 
PsychINFO, Global Health, CENTRAL, ClinicalTrials.gov, WHO ICTRP) without language 
restrictions to identify relevant published, unpublished, completed or ongoing trials. We 
developed a comprehensive search around two key concepts (STIs and mobile technology) and 
adapted an RCT filter (Suppl.3). We restricted the time period to 1 January 2010-19 February 
2020, but also searched lists of studies included in our previous systematic review3 covering 
January 1990-September 2010, and in other related reviews (n=48, Suppl.3), and contacted 
experts (n=11/15 responded). 
 
Study selection 
After deduplication in EndnoteX9, and pilot-testing of inclusion/exclusion criteria, two 
reviewers (sexual health experts masked to each other’s decisions) independently screened all 
titles/abstracts and potentially relevant full-text articles for eligibility. Discrepancies were 





Data extraction and study appraisal 
We developed a data extraction tool in excel for extracting various study data recommended 
by Cochrane21; we used the Cochrane risk of bias (ROB) assessment tool22  to assess ROB of 
individual studies and GRADEpro|GDT software to assess certainty of evidence (CoE) across 
studies (considering ROB in individual studies, inconsistency of results between studies, 
indirectness of evidence, imprecision and publication bias) 23 24. 
 
After piloting data extraction and ROB assessment, one reviewer extracted data and assessed 
ROB, with a second reviewer independently cross-checking after reading the whole article(s). 
Similarly, all CoE assessments were cross-checked. Disagreements were resolved by 
discussion and by consulting a third reviewer when necessary. We contacted 13 authors 
(maximum of three email attempts) for additional information/data. 
 
Data synthesis and analysis 
After summarizing studies according to type of intervention, comparison, and outcomes, we 
conducted meta-analyses, where sufficient data were available for at least two similar studies. 
We used Review Manager 5.325 for computing effect sizes and meta-analyses following 
Cochrane guidance18. 
 
First, we calculated risk ratios (RR) or odds ratios (OR) with 95% confidence intervals (CI) for 
dichotomous data, and converted dichotomous and continuous summary measures into 
standardized mean differences (SMD) where necessary to make them comparable across 
different studies and outcome measures (ensuring scales pointed in the same direction prior to 




We then conducted meta-analyses using random-effects models, due to the anticipated 
variability of included studies. If a study reported more than one relevant comparison group or 
reported outcomes separately for different subgroups, we combined them if possible, or chose 
one most comparable to other studies. We pooled results separately for outcomes assessed after 
short/medium-term (<12 months) versus long-term (≥12 months) follow-ups20. For studies 
reporting results for multiple time points, we chose one closest to the mode of time points of 
all pooled studies. Where substantial heterogeneity (I2 ≥50%)18 was present and where possible 
(one instance only), we conducted a pre-specified subgroup analysis20 and presented results in 
the main text. (Where heterogeneity was not substantial, we conducted additional subgroup 
analyses to better visualize results for pre-specified criteria, and displayed them in 




From a total of 6683 identified unique articles, we included 41 articles reporting on 22 trials 
(Figure 1, Suppl.4). Among these, 20 trials with a total of 19,551 participants were included in 
meta-analyses. We also identified 12 ongoing trials. 
 
Study characteristics 
Among the 22 included trials, 15 were published between January 2015 and February 2020, 19 
were parallel-group and three were cluster RCTs, 19 had two trial arms, and seven were pilot 
trials (Table 1, Suppl.6). Twelve trials had been conducted in HIC (US: n=6; Europe: n=3; 
Australia: n=3), and ten in LMIC (Africa: n=7; China: n=2; India: n=1); eleven focused on 
HIV, and ten targeted key populations,  including men having sex with men (MSM, n=6), sex 
workers (n=3), truckers (n=2), and/or people with alcohol use disorder (n=1). Total sample 
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sizes ranged from N=52-7606. Thirteen trials were informed by behavioural theory and 12 
involved users during intervention development. 
 
Intervention aim, content, mode of delivery and duration varied, ranging from single re-testing 
reminder text messages to complex interventions delivered via different modes over months 
(1-6 months: 64%; >6 months:14%) targeting various behaviours.  
Seven trials targeted diagnosis-related behaviour only (HIC: n=1, LMIC: n=6) mostly sending 
unidirectional text messages over short time-periods (<4 weeks) to remind people to (re-)test 
for HIV/STIs or in one case to notify partners. One stepped-wedge (4x3 months) cluster RCT 
educated and encouraged participants to test for HIV via a multi-component, smartphone 
application-based intervention.  
Six trials targeted preventive behaviour only, and nine targeted both preventive, and STI/HIV-
testing behaviour; fifteen educated and reminded participants about condom use, and seven 
also taught condom use (negotiation) skills; a few interventions also discussed contraception, 
illegal drug use, and/or delay of first sex/abstinence. Only two trials included treatment-related 
messages to educate and remind people about taking STI medications and abstaining from sex 
until treatment-completion.  
Overall, thirteen trials included only unidirectional messages; eleven included both 
unidirectional and bidirectional messages, for example, where participants could respond to 
quiz questions, or had the option to text a number back to hear more; Six interventions also 
involved direct interaction with peers or health providers (as part and/or on top of the mHealth 
intervention), and five directed participants to external online or telephone services, such as 




Comparisons included different types of mobile interventions and control arms (Table 1). The 
majority (82%) of trials included mobile phone text messaging/short message services (SMS) 
as mode of delivery; most of these compared SMS interventions to inactive control groups not 
containing any active SMS component. In two trials though, control group participants 
obtained SOC that already contained sexual health-related SMS (in lower dosage). Two other 
trials compared SMS interventions ‘blended’ with in-person interventions to inactive controls. 
Only four (18%) of the eligible trials evaluated mHealth interventions with a ‘push’ component 
other than SMS, including person-delivered Facebook messages (n=1 trial) and messages sent 
via smartphone applications (app, n=2 via ‘WeChat’ and n=1 via another app). 
 
Outcomes included mostly behavioural outcomes with 68% of trials assessing condom use and 
64% assessing STI/HIV-(self)testing; only three trials assessed biological outcomes, and only 
one trial assessed adverse events. Most trials (82%) assessed outcomes after short/moderate-
term follow-ups. 
 
Among the 12 ongoing trials all target key/specific populations, seven use behavioural theory, 
five assess biological outcomes, and one adverse events (Suppl.5). 
 
Risk of bias and certainty of evidence 
ROB regarding random sequence generation and allocation concealment was low in 86% and 
50% of trials respectively and unclear in the remaining trials. ROB for other domains varied 
(details in Suppl.7).  
The certainty of evidence (CoE) was very low or low for adverse events, all biological and 
most behavioural outcomes; CoE was moderate for short/medium-term condom use and 
STI/HIV-testing outcomes in two comparisons (Table 2, details in Suppl.8). 
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Table 1 – Characteristics of included studies 
Study Design 
(name) 








RCT, 5-arm People listed in mobile phone 
database, South Africa 
(N=2553) 
D Four SMS intervention arms (3 or 10 
motivational vs 3 or 10 informational SMSs) 
vs no intervention  
[HIV testing, Costs (1m3w)] ^ 
Delamere 
(2006)28 
RCT, 2-arm Young persons clinic clients, 
Ireland (N=60) 
P Weekly SMS messages for 3 m vs no 
intervention 
Condom use (3m) 
Downing 
(2013)29 
RCT, 3-arm SH service clients, Australia 
(N=94) 
D One SMS reminder message at 10-12 weeks vs 
SOC 
STI testing (3-4m) 
Free 
(2016)30 
Pilot RCT, 2- 
arm (Safetxt) 
Young people attending SH 
services, UK (N=200) 
P, D, T SMS messages (initially up to 4 per day, 
gradually less, at the end 1 per month) over 12 
m vs monthly SMSs checking contact details 
STI occurrence (3, 12m), AE 
(12m), Condom use, STI testing 




arm (S5 Proj.) 
Mobile advertising service 
subscribers, Australia 
(N=7606) 
P, D Safer sex SMSs (fortnightly during summer 
plus 8 at annual events) vs sun safety SMS 
placebo control  




RCT, 2-arm Transient/resident populations 
near roadside clinics, SA, Zim-
babwe, Mozambique (N=1783) 
P, D SMS messages (daily during the first week, 
then weekly) for 29 weeks (about 6 months) vs 
SOC 
Condom use, HIV testing, self- 




RCT, 3-arm Male truckers registered in 
EHRS, Kenya (N=2262) 
D Enhanced SOC (3 SMS reminders) vs SOC (1 
SMS reminder) 
HIV testing, SMS costs (2m) 
Kelvin 
(2019b)34 
RCT, 3-arm Female sex workers registered 
in EHRS, Kenya (N=2196) 
D Enhanced SOC (3 SMS reminders) vs SOC (1 
SMS reminder) 
HIV testing, SMS costs (2m) 
Lim 
(2012)35 
RCT, 2-arm Music festival attendees, 
Australia (N=994) 
P, D SMS messages (3-4 per w) and emails (less 
than monthly) over 12 m vs no intervention 
Condom use, STI testing, STI 
knowledge (6, 12m) 
Mimiaga 
(2017)36 
Pilot RCT,  
2-arm 
MSM engaging in sex work, 
India (N=100)                                             
P Blended SMS intervention (phone and in-
person sessions & daily SMS for 3 m) vs SOC 
Condom use (3m) 
Mugo 
(2016)37 
RCT, 2-arm Health facility/ pharmacy 
clients, Kenya (N=410) 
D SMS and phone call (or in-person) reminders 
vs SOC appointment card 







Youth Health Clinic attendees, 
Sweden (N=433) 
P, D Interactive smartphone app, incl. info sent over 
6 months vs ‘dummy’ app with questionnaires 







Pregnant women with positive 
syphilis test, Uganda (N=442) 
D Weekly SMS reminders for up to 8 weeks vs 
SOC partner notification slips 




RCT, 3-arm  
(Project Tech 
Support 2) 
MSM who use 
methamphetamine, US 
(N=286) 
P SMS conversation with PHE, automated SMS 
and self-monitoring assessment (SMA) vs 
automated SMS and SMA vs SMA only   
Condom use (9 m), costs 
Rinehart 
(2019)41 
Pilot RCT,  
2-arm (t4she) 
Community health centre 
patients, US (N=244) 
P Automated SMS messages over 12 weeks vs 
SOC 
Condom use, STI knowledge, 





Students at 38 secondary 
schools, Ghana (N=756) 
P Interactive quiz SMS vs unidirectional SMS 
intervention vs placebo control (malaria info) 
Condom use, age at sexual debut 
(15 m), knowledge (3, 15m) 
Suffoletto 
(2013)43 
Pilot RCT,  
2-arm 
Female emergency department 
patients, US (N=52) 
P SMS intervention over 12 w vs SMS 
announcing time of final survey completion 






MSM using social networking 
mobile app, China (N=1381) 
D Biweekly WeChat images/texts over 3 m and 
HIV self-testing platform vs wait list control 
HIV testing, self-efficacy, stigma, 





Patients with pelvic inflam. 
disease, US (N=292) 
P, D, T Blended SMS intervention (daily SMS for 2 w, 
then weekly for 1 m plus 1 nurse visit) vs SOC 
STI occurrence, condom use (3 m) 
treatment compliance, PN (2 w) 
Ybarra 
201746 
Pilot RCT,  
2-arm (G2G) 
Men identifying as gay, 
bisexual and/or queer, US 
(N=302) 
P, D SMS messages for 5 w (5-10 per day) plus 
booster vs SMS placebo control (general health 
info) 
Condom use, abstinence, HIV 
testing, knowledge, perceived 





Mostly African American and 
Latino MSM, US (N=122) 
P, D Peer-delivered Facebook intervention for 12 
weeks vs placebo control (general health info) 





MSM, China (N=100) P, D Smartphone App-based info and weekly 
messages plus HIVST kits vs HIVST kits only  
Condom use, HIV testing (6 m) 
 
* Interventions, comparators and outcomes relevant to this review only; | P, preventive-, D, diagnosis-, T, treatment-related behaviour; ~ post baseline; ^data 
unextractable due to figures not adding up and failed attempts to obtain response from authors; AE, adverse events; App, application; (C-)RCT, (Cluster-) 
randomized controlled trial; HIVST, HIV self-testing; MSM, men having sex with men; EHRS, electronic health record system; PHE, peer health educators; 
PN, partner notification; SA, South Africa; SH, sexual health; SMS, short message service; SOC, standard of care; treatm. compl., compliance with STI 
treatment instructions (drug adherence and abstinence till infection has cleared); behav., behaviour; m, month(s), w, week(s); vs, versus 
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Results of meta-analyses by comparison, outcome and certainty of evidence 
Below and in table 2, we report results separately for different comparisons and outcomes 
(details in Suppl.9). Figure 2 includes forest plots for most important outcomes (predefined in 
protocol) of moderate CoE only (for others and subgroup analysis see Suppl.10). 
 
SMS intervention versus inactive control 
Biological outcomes: Meta-analyses of biological outcomes were not possible, as only one 
pilot trial30 examined long-term STI/HIV-occurrence (cumulative chlamydia incidence), and 
short/medium-term  STI/HIV-occurrence with low CoE due to imprecision (table 2). 
Adverse events: Similarly, only one pilot trial30 reported on adverse events with very low CoE. 
Behavioural outcomes: The CoE for intervention effects on behavioural outcomes ranged from 
very low to moderate, and meta-analyses were only possible for five outcomes: Long-term 
condom use was examined by three trials30 35 42, but CoE was low; nine trials28 30-32 35 40 41 43 46 
did not show an effect on short/medium-term condom use (SMD 0.02, CI -0.09-0.14, moderate 
CoE, Figure 2). CoE was very low for long-term STI/HIV-testing (2 trials30 35), but was 
moderate for short/medium-term STI/HIV-testing (7 trials29-32 35 37 46); here, a benefit was 
detected (OR 1.83, CI 1.41-2.36, Figure 2). Two trials30 39 targeted partner notification, but 
CoE was very low. 
 
Other review outcomes: Four trials31 35 41 46 revealed a small effect on STI/HIV-knowledge 
(SMD 0.22, CI 0.09-0.36) with moderate CoE, and two trials41 46 failed to show a statistically 
significant effect on condom use self-efficacy (SMD 0.24, CI -0.01-0.48), but CoE was low. 





SMS intervention versus SOC control containing active SMS component 
Behavioural outcomes: Two trials33 34 conducted in the same setting failed to show an effect 
on STI/HIV-testing (OR 1.00, CI 0.68-1.47, moderate CoE, Figure 2). 
 
SMS intervention blended with in-person contact versus inactive control 
Behavioural outcomes: Only one trial45 examined short/medium-term STI/HIV-occurrence, 
with very low CoE. CoE for all behavioural outcomes was low, including short/medium-term 
condom use (2 trials36 45), STI treatment-related abstinence, drug adherence and partner 
notification (1 trial45).  
 
Facebook intervention versus inactive control 
No meta-analysis was possible and CoE for the only reported outcome was very low (1 trial47). 
  
Smartphone App intervention versus inactive control 
Behavioural outcomes: A single trial38 assessed short/medium-term STI/HIV-occurrence, and 
CoE was low. It was also low for short/medium-term condom use (2 trials38 48). CoE for self-
reported short/medium-term STI/HIV-testing was low when three trials38 44 48 were pooled 
(partly due to heterogeneity), but was moderate in a subgroup analysis with two trials44 48 that 
displayed an important benefit (RR 1.40, CI 1.22-1.60). One trial48 also reported objectively 
confirmed STI/HIV-testing results, but CoE was low. 
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Table 2 – Summary of Findings (for predefined review outcomes) 
Outcome# Effect Certainty* Description^ 
№ of participants (studies)  Relative (CI) Absolute~(CI) 
  
SMS interventions vs inactive controls 
STI/HIV occurrence, obj. at ≥12 m;  
N=200 (1 RCT)30 
RR 0.61 
(0.28 to 1.34) 
58 fewer per 1000  
(107 fewer to 49 more) 
⨁⨁◯◯ 
LOW 
SMS interventions may result in little to no 
difference in STI/HIV occurrence at ≥12 m. 
STI/HIV occurrence, obj. at <12 m;  
N=171 (1 RCT)30 
RR 2.17 
(0.56 to 8.40) 
39 more per 1,000 
(15 fewer to 249 more) 
⨁⨁◯◯ 
LOW 
SMS interventions may result in little to no 
difference in STI occurrence at <12 m. 
Adverse events - car accident where partic. was 
driver, at ≥12m; N=157 (1 RCT)30 
RR 2.08 
(0.19 to 22.45)  
14 more per 1,000 
(10 fewer to 268 more) 
⨁◯◯◯ 
VERY LOW 
The evidence is very uncertain about the effect of 
SMS interventions on adverse events. 
Condom use, subj. at ≥12 m);  
N=667 (3 RCTs)30 35 42 
OR 1.10 
(0.77 to 1.56)  
-~ ⨁⨁◯◯ 
LOW 
SMS interventions may not change condom use at 
≥12 m.  
Condom use, subj. at <12 m) 
N=2307 (9 RCTs)28 30-32 35 40 41 43 46 
SMD 0.02  
(-0.09 to 0.14)  
-~ ⨁⨁⨁◯ 
MODERATE 
SMS interventions probably do not increase condom 
use at <12 m. 
STI/HIV testing, obj. or subj. at ≥12 m; N=492 (2 
RCTs)30 35 
OR 0.86 
(0.25 to 2.95)  
23 fewer per 1,000 
(138 fewer to 222 more) 
⨁◯◯◯ 
VERY LOW 
The evidence is very uncertain about the effect of 
SMS interv. on STI/HIV testing at ≥12 m.  
STI/HIV testing, obj. or subj. at <12 m); N=2151 
(7 RCTs)29-32 35 37 46 
OR 1.83 
(1.41 to 2.36)  
150 more per 1,000 
(85 more to 211 more) 
⨁⨁⨁◯ 
MODERATE 
SMS interventions probably lead to increased 
STI/HIV testing at <12 m.  
Compliance - took treatment for curable STI; 
N=38 (1 RCT)30 
RR 0.95 
(0.82 to 1.09)  
50 fewer per 1,000 
(180 fewer to 90 more) 
⨁◯◯◯ 
VERY LOW 
The evidence is very uncertain about the effect of 
SMS interv. on treatment adherence. 
Compliance - abstinence during treatment of 
curable STI; N=37 (1 RCT)30 
RR 1.12 
(0.90 to 1.40)  
101 more per 1,000 
(84 fewer to 337 more) 
⨁◯◯◯ 
VERY LOW 
The evidence is very uncertain about the effect of 
SMS interv. on treatment-related abstinence. 
Partner notification; 
N=336 (2 RCTs)30 39 
OR 1.04 
(0.31 to 3.48)  
7 more per 1,000 
(152 fewer to 285 more) 
⨁◯◯◯ 
VERY LOW 
The evidence is very uncertain about the effect of 
SMS interventions on partner notification.  
SMS interventions vs SOC with active SMS 
STI/HIV testing, obj. or subj., at <12 m; N=2956 
(2 RCTs)33 34 
OR 1.00 
(0.68 to 1.47)  
0 fewer per 1,000 
(11 fewer to 16 more) 
⨁⨁⨁◯ 
MODERATE 
SMS interv. probably don’t change STI/HIV testing 
if compared to active SMS controls 
Blended SMS interventions vs inactive control 
STI/HIV occurrence, obj., at <12 m);  
N=260 (1 RCT)45 
OR 0.40 
(0.15 to 1.09)  
60 fewer per 1,000 
(87 fewer to 8 more) 
⨁◯◯◯ 
VERY LOW 
The evidence is very uncertain about the effect of 
blended SMS interv. on STI/HIV occ.  
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Condom use, at < 12 m 





Blended SMS interventions may increase condom 
use slightly. 
Compliance - took treatment for curable STI; 
N=260 (1 RCT)45 
OR 0.64 
(0.39 to 1.05)  
109 fewer per 1,000 
(217 fewer to 12 more) 
⨁⨁◯◯ 
LOW 
Blended SMS interv. may result in little to no 
difference in STI treatment adherence. 
Compliance -abstinence during treatment of 
curable STI; N=260 (1 RCT)45 
OR 0.73 
(0.39 to 1.37)  
49 fewer per 1,000 
(175 fewer to 40 more) 
⨁⨁◯◯ 
LOW 
Blended SMS interv. may result in little to no 
difference in treatment-related abstinence. 
Partner notification; 
N=260 (1 RCT)45 
OR 0.84 
(0.36 to 2.00)  
14 fewer per 1,000 
(116 fewer to 39 more) 
⨁⨁◯◯ 
LOW 
Blended SMS interventions may result in little to no 
difference in partner notification.  
Facebook interventions vs inactive control 
STI/HIV testing, obj., at <12 m;  
N=122 (1 RCT)47 
MD, 24 pp  
(8 to 41 pp)  
-~ ⨁◯◯◯ 
VERY LOW 
The evidence is very uncertain about the effect of 
Facebook interv. on STI/HIV testing 
Smartphone App interventions vs inactive control 
STI/HIV occurrence, subj. at <12 m;  
N=433 (1 RCT)38 
OR 1.03 
(0.69 to 1.55)  
6 more per 1,000 
(74 fewer to 101 more) 
⨁⨁◯◯ 
LOW 
App interv. may result in little to no difference in 
self-reported STI/HIV occurrence 
Condom use at < 12 m;  
N=485 (2 RCTs)38 48 
OR 0.85 
(0.53 to 1.37)  
25 fewer per 1,000 
(84 fewer to 55 more) 
⨁⨁◯◯ 
LOW 
App interventions may result in little to no 
difference in condom use.  
STI/HIV testing, obj.| at <12 m;  
N=100 (1 RCT)48| 
RR 4.56 
(2.49 to 8.35)  
641 more per 1,000 
(268 to 1,000 more) 
⨁⨁◯◯ 
LOW 
App interventions may result in a large increase in 
STI/HIV testing. 
STI/HIV testing, subj.| at <12m;  
N=2971 (3 RCTs)38 44 48 
RR 1.27 
(1.05 to 1.52)  
-~ ⨁⨁◯◯ 
LOW 
App interventions may result in a slight increase in 
STI/HIV testing. 
Subgroup analysis: STI/HIV testing, subj., at  
<12 m) - MSM, LMIC; N=2538 (2 RCTs)44 48 
RR 1.40 
(1.22 to 1.60)  
-~ ⨁⨁⨁◯ 
MODERATE 
App interv. probably increase STI/HIV testing 
slightly among MSM in LMIC 
Subgroup analysis: STI/HIV testing, subj., at <12 
m) - general population, HIC; N=433 (1 RCT)38 
RR 1.1 
(1.0 to 1.2) 
77 more per 1,000 
(0 fewer to 153 more) 
⨁⨁◯◯ 
LOW 
App interv. may result in little to no difference in 
STI/HIV testing among general populations in HIC. 
CI, 95% confidence interval; MD, mean difference; MSM, men having sex with men; OR, odds ratio; pp, percentage points; RCT, randomized controlled trial; RR, risk ratio; 
SMD, standardized mean difference; SMS, short message service (mobile phone text messaging); SOC, standard of care; STI, sexually transmitted infection; m, month(s) – 
referring to the number of months from baseline until the outcome assessment time point; obj., objectively reported, e.g. confirmed by laboratory or clinic records; subj., 
subjective/self-reported, e.g. participants responding to survey question; # Outcomes relevant to this review, as pre-specified in protocol; ^ Here (and throughout the 
manuscript) we used standardized language19 24; ~ Absolute effects generated in GRADEpro|GDT24 if sufficient data on baseline risks were available; | Obj. and subj. 
outcomes presented separately here, as one of the studies 48 reported both obj. and subj. outcomes; * Details on the certainty of evidence can be found in Suppl.8 (GRADE 
evidence profiles); Certainty definitions24: HIGH - Further research is very unlikely to change our confidence in the estimate of effect; MODERATE - Further research is 
likely to have an important  impact on our confidence in the estimate of effect and may change the estimate.;  LOW - Further research is very likely to have an important 




This review pooled data from 22 RCTs with a total of 19,551 participants to explore effects of 
specific mHealth interventions on various predefined outcomes. For biological outcomes and 
adverse events, meta-analyses were not possible, as too few studies assessed these outcomes. 
Meta-analyses were possible, however, for some of the behavioural outcomes, and allow us to 
state the following with moderate certainty: in the short/medium-term, SMS interventions 
probably make little or no difference to condom use, but moderately increase STI/HIV-testing 
if compared to inactive controls that do not already contain an active SMS component. 
Similarly, smartphone applications with push content probably increase STI/HIV-testing if 
targeting MSM in LMIC. CoE ranged from very low to low for all other review outcomes and 
comparisons, apart from a small positive effect of SMS interventions on STI/HIV-knowledge, 
for which CoE was moderate. 
 
Our results provide greater certainty evidence corroborating findings of a Cochrane review on 
targeted client communication via mobile devices (with literature search through Jul/2017)14. 
It had only partly overlapping comparisons and outcomes, and for those relevant to our current 
review pooled fewer trials and had lower CoE, but showed similar effects; findings suggested 
positive effects on short/medium-term STI-testing (low certainty), and no effect on condom 
use (very low CoE). CoE was also very low for STI-occurrence, and unintended consequences. 
Similarly, another recently published review13 (with comprehensive search through Aug/2013, 
and Medline search till Mar/2017) identified fewer trials, but also exhibited no effect of SMS 
interventions on condom use (based on two trials only), and a positive effect on testing (based 




Contrary to our findings, Xin and colleagues16 yielded small positive effects on condom use 
among MSM when pooling various eHealth interventions; statistical heterogeneity was 
substantial though, and the review included also nonrandomised studies. Swanton and 
colleagues49 previously showed that a positive effect of new-media interventions on condom 
use disappeared when only RCTs were included, but a positive effect on STI-testing remained. 
The inclusion of nonrandomised studies might also have influenced the slight positive effect 
of technology-based interventions on condom use for both STI prevention and/or contraception 
among youth in another review50; here, moderator analyses exhibited statistically significant 
effects only for follow-ups <6 months. The same review also reported increasing knowledge, 
but not self-efficacy, in line with our findings. 
 
Our review has added evidence from newly published studies, which allowed us to include 
RCTs only and still be able to pool data and generate meaningful results for at least some of 
our outcomes. We have carried out the review and reported results following internationally 
recognized guidelines18 19 22 23. In a few instances, we had to exclude studies from meta-
analyses, or include only part of the results, where additional information/data could not be 
obtained. Our eligibility criteria were broad regarding populations/settings, but relatively 
narrow regarding interventions. We restricted mHealth interventions to those that reported a 
‘push’ component, as these might also reach people, who would not readily interact with apps 
or seek information on the internet anyway. This does not imply that other types of mHealth 
interventions are less important. To reduce the scope of our review, we also excluded HIV- and 
reproductive health-related studies not directly relevant to the sexual transmission of curable 
STIs; we recognize, however, that integrating related services51 and linking various steps in the 




It exceeded the scope of our review to explore various motivational and structural factors that 
might explain our results53 54 55; for example, even if behavioural interventions can influence 
through informing, reminding, teaching skills and supporting people by linking them to health 
services56, this might not be sufficient to achieve condom use, where access to condoms is a 
problem or power imbalances between partners are too stark. On the other hand, it is possible 
that condom use might be increased by further improving the quality of behavioural mHealth 
interventions. To achieve this, experts have called for increased use of behavioural theory 
(reported by 59% of our included trials), user involvement (55% of trials) and tailoring (36% 
of trials)12 57. The trial reports did not always contain sufficient detail about intervention 
development and content, but generally, the content of mHealth interventions was less 
comprehensive than the content of effective condom promotion face-to-face interventions we 
reviewed previously58.  
 
Our positive findings regarding STI/HIV-testing, should encourage health care providers and 
policymakers to consider integrating mHealth interventions with other types of services, 
including eHealth platforms59 60 that facilitate anonymous partner notification, and self-
testing/self-sampling with remote result notification and postal treatment. This becomes 
particularly advantageous where access to sexual health services is restricted for socio-
economic or other reasons, including during Covid-19-related lockdowns61. Further 
implementation research on such integration is needed. Researchers should also assess costs 
and explicitly measure adverse events/potential harm62 63. Ongoing trials64 65 will report the 







- In the short/medium-term, SMS interventions probably make little or no difference to condom 
use, but increase STI/HIV-testing if compared to controls without an active SMS component.  
- In the short/medium-term, smartphone applications with content delivered to participants 
probably increase STI/HIV-testing among MSM in LMIC. 
- Further evidence on the cost-effectiveness and effect of mHealth interventions on STI 
treatment-adherence, partner notification, biological and other outcomes with long-term 
follow-ups is needed. 
- Future RCTs should explicitly measure and report adverse events/ unintended consequences 
of sexual health interventions delivered to participants by mobile technology. 
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Figure legends 
Figure 1 - Flow chart of the study selection process 
Figure legend:  
# Details and list of excluded articles with reasons in Suppl.4    
* n=22 included studies reported in n=41 articles; n=12 ongoing studies reported in n=13 
articles (Suppl.5) 
Flow chart adapted from:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group 
(2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA 





Figure 2 – Forest plots of studies comparing interventions to inactive controls for outcomes of 
moderate certainty of evidence 
Figure legend: HIC, high-income countries; LMIC, low- and middle- income countries; ICC, 
intra-cluster correlation coefficient; CI, confidence interval; AOR, adjusted odds ratio; RCT, 
randomised controlled trial; SE, standard error; SMD, standardised mean difference; SMS, 
short message service (mobile phone text messaging); STI, sexually transmitted infection; 
TXT, text messaging; f/m comb., female/male combined; m, month(s); w, week(s);  
Note: Studies within forest plots are sorted by objectively confirmed versus self-reported 
outcome (where applicable) and by study weight 
 
Risk of bias domains: 
(A)  Random sequence generation (selection bias) 
(B)  Allocation concealment (selection bias) 
(C)  Blinding of participants and personnel (performance bias) 
(D)  Blinding of outcome assessment (detection bias) 
(E)  Incomplete outcome data (attrition bias) 
(F)  Other bias (e.g. contamination bias) 
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